z-logo
open-access-imgOpen Access
Mesenchymal stem cells, Vitamin and Zinc as therapeutic cells and factors of COVID-19
Author(s) -
Jamshid Ayatollahi,
Seyed Hossein Shahcheraghi,
Marzieh Lotfi,
Mahdie Hamidfar,
Mohammad Dehghan Niri,
Azam Fazilati
Publication year - 2020
Publication title -
chinese journal of medical research
Language(s) - English
Resource type - Journals
eISSN - 2663-8053
pISSN - 2618-091X
DOI - 10.37515/cjmr.091x.3301
Subject(s) - coronavirus , covid-19 , mesenchymal stem cell , virology , medicine , biology , outbreak , disease , infectious disease (medical specialty) , pathology
2019 Coronavirus disease (COVID-19) occurred in Wuhan City, Central China, and has spread rapidly in many countries in world. COVID-19 is produced by a new coronavirus called the extreme acute respiratory coronavirus syndrome 2 (SARS-CoV2) [Recently identified as the 2019 novel coronavirus (2019- nCoV)] [1]. However, there was no official approval of an antiSARS-CoV-2 drug or vaccine due to the lack of sufficient evidence. Scientists are trying to improve COVID-19 by the new drugs and methods [2].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here